December 2011. Volume 7. Number 4

Does the neonatal pulse oximetry screening improve the detection of congenital heart disease?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S et al; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 2011;378:785-94.
Reviewers: Ochoa Sangrador C1, Molina Arias M2, Aparicio Sánchez JL3.
1Servicio de Pediatría. Hospital Virgen de la Concha. Zamora. España.
2Servicio de Gastroenterología y Nutrición. Hospital Infantil Universitario La Paz. Madrid. España.
3Servicio de Pediatría. Hospital General de Lanzarote. Gran Canaria. España.
Correspondence: Carlos Ochoa Sangrador. Email: cochoas@meditex.es
Reception date: 17/10/2011
Acceptance date: 23/10/2011
Publication date: 26/10/2011

Abstract

Authors' conclusions: pulse oximetry is a safe and feasible method of screening that improves screening procedures currently available. It allows an early identification of congenital heart diseases and other diseases.

Reviewers' commentary: although neonatal pulse oximetry is acceptably valid, feasible to implement and a cheap method of screening, the expected diagnostic improvement will be low in children born after pregnancies submitted to well done ultrasound scans and properly explored in the early hours of life. Well-conducted cost-benefit studies are needed to assess its economic impact.

How to cite this article

Ochoa Sangrador C, Molina Arias M, Aparicio Sánchez JL. ¿Mejora el cribado neonatal con pulsioximetría la detección de cardiopatías congénitas? Evid Pediatr. 2011;7:89.

AVC | Critically appraised articles

Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S et al; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 2011;378:785-94.
Reviewers: Ochoa Sangrador C1, Molina Arias M2, Aparicio Sánchez JL3.
1Servicio de Pediatría. Hospital Virgen de la Concha. Zamora. España.
2Servicio de Gastroenterología y Nutrición. Hospital Infantil Universitario La Paz. Madrid. España.
3Servicio de Pediatría. Hospital General de Lanzarote. Gran Canaria. España.
Correspondence: Carlos Ochoa Sangrador. Email: cochoas@meditex.es
Reception date: 17/10/2011
Acceptance date: 23/10/2011
Publication date: 26/10/2011

How to cite this article

Ochoa Sangrador C, Molina Arias M, Aparicio Sánchez JL. ¿Mejora el cribado neonatal con pulsioximetría la detección de cardiopatías congénitas? Evid Pediatr. 2011;7:89.

References

  1. Schultz AH, Localio AR, Clark BJ, Ravishankar C, Videon N, Kimmel SE. Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics. 2008;121:751-7.
  2. Thangaratinam S, Daniels J, Ewer AK, Zamora J, Khan KS. Accuracy of pulse oximetry in screening for congenital heart disease in asymptomatic newborns: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2007;92:F176-80.
  3. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;26:832-5.
  4. Rodríguez Dehli C, Ariza Hevia F, Riaño Galán I, Moro Bayón C, Suárez Menéndez E, Mosquera Tenreiro C et al. Epidemiología de las cardiopatías congénitas en Asturias durante el periodo 1990-2004. An Pediatr (Barc). 2009;71:502-9.
26/10/2011

Linked Comment